Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro

Planta Medica

Volumn 74, Issue 5, 2008, Pages 527-531

  Abdelouahab, Nassima ^a   Heard, Charles M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Devils Claw; Harpagophytum procumbens; Inflammation; Pedaliaceae; Skin; Topical delivery; Transcutaneous delivery

Indexed keywords

ALCOHOL; HARPAGIDE; HARPAGOPHYTUM PROCUMBENS EXTRACT; MACROGOL 400;

ARTICLE; CONTROLLED STUDY; DIELECTRIC CONSTANT; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG STRUCTURE; HARPAGOPHYTUM PROCUMBENS; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PEDALIACEAE; PHYSICAL CHEMISTRY; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; GLYCOSIDES; HARPAGOPHYTUM; SWINE;

HARPAGOPHYTUM PROCUMBENS; PEDALIACEAE; SUS;

EID: 43249128328     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1074500     Document Type: Article

References (27)

1. Ernst E, Chrubasik S. Phyto-anti-inflammatories: A systematic review of randomised, placebo-controlled, double-blind trials. Rheum Dis Clin North Am 2000; 26: 13-27
2. Baghdikian HB, Lanhers MC, Fleurentin J, Ollivier E, Maillard C, Balansard G et al. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med 2000; 63: 171-6.
3. Council of Europe (COE) - European Directorate for the Quality of Medicines. European Pharmacopoeia, Volumes I and II, 5th edition Strasbourg: European Directorate for the Quality of Medicines; 2004
4. Chrubasik S, Conradt C, Roufogalis BD. Effectiveness of Harpagophytum extracts and clinical efficacy. Phytother Res 2004; 18: 187-9
5. Chantre P, Cappelaere D, Leblan D, Guedon J, Vandermander J, Fournie B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000; 7: 177-83
6. Chrubasik S, Zimper C, Schuett U, Ziegler R. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 1996; 3: 1-10
7. Kundu JK, Mossanda KS, Na HK, Surh YJ. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC. on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett 2005; 218: 21-31
8. Boje K, Lechtenberg M, Nahrstedt A. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 2003; 69: 820-5
9. Stewart KM, Cole D. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: The devil's in the details. J Ethnopharmacol 2005; 100: 225-36
10. Joubert E, Manly M, Gray BR, Schulz H. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (Devil's Claw) root. J Agric Food Chem 2005; 53: 3493-502
11. Fiebich BL, Heinrich M, Hiller KO, Kammerer N. Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 2001; 8: 28-30
12. Lanhers MC, Fleurentin J, Mortier F, Vinche A, Younos C. Antiinflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med 1992; 58: 117-23
13. Loew D, Mollerfeld J, Schrodter A, Puttkammer S, Kaszkin M. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and in vivo. Clin Pharmacol Ther 2001; 69: 356-64
14. McGregor G, Fiebich B, Wartenberg A, Brien S, Lewith G, Wegener T. Devil's Claw (Harpagophytum procumbens): An anti-inflammatory herb with therapeutic potential. Phytochem Rev 2005; 4: 47-53
15. Benito PB, Lanza AMD, Sens AMS, Galindez JD, Matellano LF, Gomez AS et al. Effects of some iridoids from plant origin on arachidonic acid metabolism in cellular systems. Planta Med 2000; 66: 324-8
16. Moussard C, Alber D, Toubin MM, Thevenon N, Henry JC. A drug used in traditional medicine, Harpagophytum procumbens: No evidence for NSAID-like effect on whole blood eicosanoid production in human. Prostaglandins Leukot Essent Fatty Acids 1992; 46: 283-6
17. Tippler B, Syrovets T, Plaza N, Loew D, Simmet T. Harpagophytum procumbens DC used in traditional medicine inhibits eicosanoid biosynthesis in human whole blood. Int J Tissue React 1997; 19: 101-2
18. Jang MH, Lim S, Han SM, Park HJ, Shin I, Kim JW et al. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 2003; 93: 367-71
19. Kaszkin M, Beck KF, Koch E, Erdelmeier C, Kusch S, Pfeilschifter J et al. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 2004; 11: 585-95
20. Abdelouahab N, Heard CM. Effect of Harpagophytum procumbens and its major iridoid glycosides on epidermal COX-2 in vitro J Nat Prod, in press
21. Blumenthal M, Busse WR, Goldberg A. The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines Boston: Integrative Medicine Communications; 2004: 120-1
22. Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N et al. Porcine ear skin: an in vitro model for human skin. Skin Res Technol 2007; 13: 19-24
23. Heard CM, Monk BV, Modley AJ. Binding of primaquine to epidermal membranes and keratin. Int J Pharm 2003; 257: 237-44
24. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000; 9: 65-6
25. Arnold K, Hermann A, Pratsch L, Gawrisch K. The dielectric properties of aqueous solutions of poly(ethylene glycol) and their influence on membrane structure. Biochem Biophys Acta 1985; 815: 515-8
26. Moser K, Kriwet K, Naik A, Kalia YN, Guy YN. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001; 52: 103-12
27. Heard CM, Kung D, Thomas CP. Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the pull effect. Int J Pharm 2006; 321: 167-70